INS and Hypoglycemia: An intriguing study by Yen et al. found that patients with liver cirrhosis and insulin-resistant T2DM that use insulin injection therapeutics had significantly elevated risks of death, as well as hypoglycemia, and liver- and cardiovascular complications, compared with those that have the same conditions but did not use insulin injections [44].